Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
259
259 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- NWRD09Phase 22 trials
Newish Biotech (Wuxi) Co., Ltd. · High-grade Squamous Intraepithelial Lesion (HSIL), Persistent HPV16 Infection
- Personalized Neoantigen Peptide VaccinePhase 22 trials
Seqker Biosciences, Inc. · Solid Tumors, Advanced Cancer, Recurrent Cancer
- RBD1016Phase 22 trials
Ribocure Pharmaceuticals AB · Chronic Hepatitis D, Chronic Hepatitis b
- rC19Novavax's adjuvanted recombinant COVID-19Phase 22 trials
Sanofi · COVID-19 Immunization, Influenza Immunization
- rhu-pGSNrecombinant human gelsolin, Recombinant human plasma gelsolin pre-exposurePhase 22 trials
BioAegis Therapeutics Inc. · Acute Respiratory Distress Syndrome, Infections, Decompression Sickness
- RSV vaccine candidatePhase 22 trials
Sanofi · Respiratory Syncytial Virus Infection, Healthy Volunteers, Respiratory Syncytial Virus Immunization
- STAR0602InvikafuspPhase 22 trials
Marengo Therapeutics, Inc. · Triple Negative Locally Advanced Non-resectable Breast Cancer, HR+, HER2-, Advanced Breast Cancer, Advanced Solid Tumors
- TNP-2092rifaquizinonePhase 22 trials
TenNor Therapeutics (Zhongshan) Limited · Prosthetic Joint Infection (PJI), Periprosthetic Joint Infection (PJI)
- TRX-100Phase 22 trials
Traws Pharma, Inc. · Influenza
- AB-729Phase 21 trial
Arbutus Biopharma Corporation · Chronic Hepatitis b
- ABI-2280Phase 21 trial
Antiva Biosciences · Human Papillomavirus Infection
- ABI-6250Phase 21 trial
Assembly Biosciences · Chronic Hepatitis D Infection
- ABO1105Phase 21 trial
Suzhou Abogen Biosciences Co., Ltd. · Respiratory Syncytial Virus
- ADX-629Phase 21 trial
Aldeyra Therapeutics, Inc. · Alcohol Hepatitis
- AFX3772Phase 21 trial
GSK · Pneumonia, Bacterial, Pneumococcal Infections, Pneumonia, Pneumococcal
- AHB-171Phase 21 trial
Ausper Biopharma Co., Ltd. · Hepatitis B, Chronic (CHB)
- AIC263029Phase 21 trial
AiCuris Anti-infective Cures AG · BK Virus Infection, BKV Infection, Kidney Transplant
- ALG-000184Phase 21 trial
Aligos Therapeutics · Chronic Hepatitis B Infection
- Alpe375Phase 21 trial
BioVersys AG · Tuberculosis Meningitis
- AlpE500Phase 21 trial
BioVersys AG · Tuberculosis Meningitis
- AlpE625Phase 21 trial
BioVersys AG · Tuberculosis Meningitis
- ApomivirFE-L-APO, drug substancePhase 21 trial
Far East Bio-Tec Co., Ltd · Influenza
- ARCT-2304Phase 21 trial
Arcturus Therapeutics, Inc. · Influenza, Human
- ASK0912Phase 21 trial
Jiangsu Aosaikang Pharmaceutical Co., Ltd. · Ventilator-associated Bacterial Pneumonia (VABP), Hospital-acquired Bacterial Pneumonia (HABP)
- AV-001Phase 21 trial
Vasomune Therapeutics, Inc. · Acute Respiratory Distress Syndrome, Viral or Bacterial Infections, Pneumonia
- AZD2693Phase 21 trial
AstraZeneca · Nonalcoholic Steatohepatitis
- AZD4117Phase 21 trial
AstraZeneca · Influenza A
- AZD5148Phase 21 trial
AstraZeneca · Clostridioides Difficile Infection
- AZD5315Phase 21 trial
AstraZeneca · Influenza A
- AZD6489Phase 21 trial
AstraZeneca · RSV Respiratory Syncytial Virus
- BemnifosbuvirAT-527Phase 21 trial
Atea Pharmaceuticals, Inc. · Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C
- BI 770371Phase 21 trial
Boehringer Ingelheim · Compensated Liver Cirrhosis, Metabolic Dysfunction Associated Steatohepatitis (MASH)
- BLB-201PIV5-vectored RSV VaccinePhase 21 trial
Blue Lake Biotechnology Inc. · Respiratory Syncytial Virus Infections
- BNT164a1Phase 21 trial
BioNTech SE · Tuberculosis
- BNT164b1Phase 21 trial
BioNTech SE · Tuberculosis
- BNT165cPhase 21 trial
BioNTech SE · Malaria
- BNT165dPhase 21 trial
BioNTech SE · Malaria
- BTZ-043Phase 21 trial
GSK · Tuberculosis
- BX004Combination of nebulized bacteriophages targeting Pseudomonas aeruginosaPhase 21 trial
BiomX Ltd · Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis (CF)
- CAL02Phase 21 trial
Eagle Pharmaceuticals, Inc. · Pneumonia, Bacterial
- CAP256V2LSPhase 21 trial
Gilead Sciences · HIV-1-infection
- CL-197Phase 21 trial
Henan Genuine Biotech Co., Ltd. · HIV-1 Infection
- CMTX-101Phase 21 trial
Clarametyx Biosciences, Inc. · Persistent Infection, Cystic Fibrosis
- DaplusiranTomligisiranPhase 21 trial
GSK · Chronic Hepatitis B Virus Infection, Hepatitis B
- Dispensing CodivirPhase 21 trial
Code Pharma · HIV, HIV Infection
- DL001ZF2G22B, F2H23HPhase 21 trial
GSK · Influenza, Human
- DL001Z-NHF2H23D, F2H23BPhase 21 trial
GSK · Influenza, Human
- ECC0509Phase 21 trial
Eccogene · Metabolic Dysfunction-associated Steatohepatitis
- EDP-938Phase 21 trial
Enanta Pharmaceuticals, Inc · RSV Infection
- EfesovirFS-1Phase 21 trial
Scientific Center for Anti-infectious Drugs, Kazakhstan · Covid19
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.